88 related articles for article (PubMed ID: 25900796)
1. Identification of clinically relevant alterations in phyllodes tumor of the breast by amplicon-based next-generation sequencing.
Tsang JY; Go EM; Tse GM
Breast Cancer Res Treat; 2015 Jun; 151(3):717-9. PubMed ID: 25900796
[No Abstract] [Full Text] [Related]
2. Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
Cani AK; Hovelson DH; McDaniel AS; Sadis S; Haller MJ; Yadati V; Amin AM; Bratley J; Bandla S; Williams PD; Rhodes K; Liu CJ; Quist MJ; Rhodes DR; Grasso CS; Kleer CG; Tomlins SA
Mol Cancer Res; 2015 Apr; 13(4):613-9. PubMed ID: 25593300
[TBL] [Abstract][Full Text] [Related]
3. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases.
Ng CC; Tan J; Ong CK; Lim WK; Rajasegaran V; Nasir ND; Lim JC; Thike AA; Salahuddin SA; Iqbal J; Busmanis I; Chong AP; Teh BT; Tan PH
J Clin Pathol; 2015 Sep; 68(9):685-91. PubMed ID: 26018969
[TBL] [Abstract][Full Text] [Related]
4. A genetic mutation panel for differentiating malignant phyllodes tumour from metaplastic breast carcinoma.
Yeong J; Thike AA; Young Ng CC; Md Nasir ND; Loh K; Teh BT; Tan PH
Pathology; 2017 Dec; 49(7):786-789. PubMed ID: 29066183
[No Abstract] [Full Text] [Related]
5. The utility of a targeted gene mutation panel in refining the diagnosis of breast phyllodes tumours.
Koh VCY; Ng CCY; Bay BH; Teh BT; Tan PH
Pathology; 2019 Aug; 51(5):531-534. PubMed ID: 31272781
[No Abstract] [Full Text] [Related]
6. Malignant phyllodes tumour with lymph node metastasis: a diagnostic conundrum resolved by next generation DNA sequencing.
Schwartz CJ; Krings G; Chen YY
Histopathology; 2024 Jan; 84(2):409-411. PubMed ID: 37706238
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of MED12 in fibroadenomas and phyllodes tumors of the breast by means of targeted next-generation sequencing.
Mishima C; Kagara N; Tanei T; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2015 Jul; 152(2):305-12. PubMed ID: 26093648
[TBL] [Abstract][Full Text] [Related]
8. Distribution of MED12 mutations in fibroadenomas and phyllodes tumors of the breast--implications for tumor biology and pathological diagnosis.
Pfarr N; Kriegsmann M; Sinn P; Klauschen F; Endris V; Herpel E; Muckenhuber A; Jesinghaus M; Klosterhalfen B; Penzel R; Lennerz JK; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2015 Jul; 54(7):444-52. PubMed ID: 25931199
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic profiling of malignant phyllodes tumors of the breast.
Nozad S; Sheehan CE; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon S; Schrock AB; Hirshfield KM; Ali N; Ganesan S; Ali SM; Miller VA; Stephens PJ; Ross JS; Chung JH
Breast Cancer Res Treat; 2017 Apr; 162(3):597-602. PubMed ID: 28210881
[TBL] [Abstract][Full Text] [Related]
10. Cystosarcoma phyllodes and gastrointestinal stromal tumors: birds of the same feather?
Vattipally VR; Raman SR; Pokala N; Ungsunan P
Am Surg; 2012 Feb; 78(2):109-11. PubMed ID: 22369816
[No Abstract] [Full Text] [Related]
11. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups.
Tan WJ; Lai JC; Thike AA; Lim JC; Tan SY; Koh VC; Lim TH; Bay BH; Tan MH; Tan PH
Breast Cancer Res Treat; 2014 Jun; 145(3):635-45. PubMed ID: 24831776
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic findings in phyllodes tumor and fibroadenomas of the breast.
Barbosa ML; Ribeiro EM; Silva GF; Maciel ME; Lima RS; Cavalli LR; Cavalli IJ
Cancer Genet Cytogenet; 2004 Oct; 154(2):156-9. PubMed ID: 15474152
[TBL] [Abstract][Full Text] [Related]
13. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.
Lim SZ; Ng CCY; Rajasegaran V; Guan P; Selvarajan S; Thike AA; Nasir NDBM; Koh VCY; Tan BKT; Ong KW; Teh BT; Tan PH
Breast Cancer Res Treat; 2019 Apr; 174(2):365-373. PubMed ID: 30511242
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic aspects of cystosarcoma phyllodes of the breast].
Demidov VP; Ostrovskaia IM; Lipkovich VS; Stranadko EF; Bakhmutskiĭ NG
Vestn Rentgenol Radiol; 1984; (4):69-71. PubMed ID: 6093341
[No Abstract] [Full Text] [Related]
15. Benign intracystic phyllodes tumor of breast.
Santosh KV; Sumana BS
Indian J Pathol Microbiol; 2010; 53(2):385-6. PubMed ID: 20551574
[No Abstract] [Full Text] [Related]
16. Cytogenetics, immunostaining for fibroblast growth factors, p53 sequencing, and clinical features of two cases of cystosarcoma phyllodes.
Woolley PV; Gollin SM; Riskalla W; Finkelstein S; Stefanik DF; Riskalla L; Swaney WP; Weisenthal L; McKenna RJ
Mol Diagn; 2000 Sep; 5(3):179-90. PubMed ID: 11070152
[TBL] [Abstract][Full Text] [Related]
17. Jejunal intussusception due to malignant phyllodes tumor of the breast.
Bilen MA; Laucirica R; Rimawi MF; Nangia JR; Cyprus GS
Clin Breast Cancer; 2012 Jun; 12(3):219-21. PubMed ID: 22381472
[TBL] [Abstract][Full Text] [Related]
18. Phyllodes tumor of the breast.
Mazy S; Hustin J; Van Reepinghen P
JBR-BTR; 1999 Jun; 82(3):118. PubMed ID: 11155875
[No Abstract] [Full Text] [Related]
19. Comparison of mutation profile between primary phyllodes tumors of the breast and their paired local recurrences.
Mitus J; Adamczyk A; Majchrzyk K; Kowalik A; Ryś J; Niemiec J
Pol J Pathol; 2020; 71(1):7-12. PubMed ID: 32429649
[TBL] [Abstract][Full Text] [Related]
20. Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers.
Reinisch M; Kuemmel S; Breit E; Theuerkauf I; Harrach H; Schindowski D; Moka D; Bettstetter M; Bruzas S; Chiari O
Orphanet J Rare Dis; 2021 Aug; 16(1):363. PubMed ID: 34399808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
